
Predictable Smear On Senior Doctors
Ian Powell discusses a predictable smear by a right-wing blogger on salaried senior doctors employed by Health New Zealand.
During my lengthy stint as Executive Director of the Association of Salaried Medical Specialists (ASMS) one of my most important functions was to negotiate the collective agreements covering salaried senior doctors and dentists employed in public hospitals.
From 1989 to 1991 these were national negotiations; until 2000 negotiations were conducted separately with each main public hospital; and then, until 2019, they were national again with all the district health boards.
On occasions these negotiations were protracted and somewhat tetchy (or tetchy plus!). It became quite predictable that, when this occurred, at some point the employers would engage in a public misrepresentation or smear in an endeavour to undermine our credibility.
To the best of my recollection these public actions never came from health ministers (a few private grumblings notwithstanding) or bloggers (although I can't dismiss the possibility that far-right blogger Cameron Slater didn't hold back; he didn't towards me on other issues).
Health Minister Simeon Brown broke the practice with his public attack on ASMS over the recent senior doctors one day strike.
This was caused by the impasse in negotiations over the national collective agreement with Health New Zealand. He began by badly misrepresenting basic salary levels.
He also claimed that the strike was causing delayed access to planned (elective) surgery. This was more than a tad rich. Under his leadership and that of his predecessors, access was already being increasingly delayed every other day of each year.
Joining in on misrepresentation and smearing
Now right-wing blogger David Farrar has jumped in support of Brown with his own smear on his Kiwiblog site (7 May): Perks smear. He alleges that salaried senior doctors employed by Health New Zealand and the Ministry of Health received 'huge perks'.
It is important to understand what perks are (and what they are not). They are additional benefits to enhance the employment package such as health insurance or a company car. They don't involve reimbursement of actual and reasonable work-related expenses.
The problem with Farrar's argument is that it is based on major errors and sloppy homework. This is not new territory for him.
I have previously called him out (11 December) for erroneous claims about resident (junior) doctors leaving for Australia: Farrar's incomplete health workforce analysis.
Farrar's hearsay evidence
On this second occasion his evidence is based on a reader writing to him claiming that salaried senior doctors employed by:
… Health NZ and the Ministry of Health get generous leave and expenses for so-called professional development – which is often an overseas conference in an exotic location – flying business class and staying in a premium hotel. I have this on good authority from someone who processes the claims! This leave and generous allowance which can accumulated for two or more years.
This is hardly robust investigation. At best it is hearsay. To begin with, Health Ministry employed senior doctors are not covered by the collective agreement covering Health New Zealand employed senior doctors.
Farrar is discussing something that applies to the latter, not the former. Further, claims to the two different employers would not be processed by the same person
By referring only to one part of the entitlement and then incorrectly calling it an allowance, he is both selective and factually wrong.
Getting to the facts
The entitlement (I was the advocate who first negotiated it) is spelt out in Clause 36.2 of the national agreement. Its first subclause (a) begins with:
The employer [Health New Zealand] requires employees [senior doctors and dentists] to be fully informed, and where possible, practised in developments within their profession. To facilitate this, employees will be entitled to leave for 10 working days (pro rata for part-time employees) continuing medical education each financial year (1 July – 30 June), plus any agreed reasonable travelling time.
This is what Farrar ignores. Continuing medical education (CME) leave is something the employer requires of this particular occupational group. This is in order to help ensure that they can perform their duties and responsibilities to the level of competence, quality and patient safety required.
The rest of sub-clause covers administrative matters, including accruals. Farrar's focus is primarily on the next sub-clause (b). He does not ignore it. Instead, he gets it badly wrong. The sub-clause reads:
Employees shall be reimbursed actual and reasonable expenses of up to $16,000 per annum (GST exclusive) and accumulated on the same basis as the working days (a) above. This reimbursement is pro-rata for part-time employees except that part-time employees whose only income from medical or dental practice is derived from their employment with one employer shall be entitled to the full reimbursement.
The fundamental distortion (or mistake if one is in a generous frame of mind) by Farrar is to call the monetary amount an allowance. It is not. It is a capped reimbursement of work-related expenses.
Furthermore, it is not an absolute $16,000. It is up to this amount subject to claims being actual and reasonable.
The specification of a specific dollar amount serves the interests of both employer and employees even though, for the latter, it is capped (potentially it could cost Health New Zealand more if there was no cap). However, the cap better enables planning and budgeting for both parties.
While use of the leave and associated reimbursements is often used for medical or dental conferences, they have to be relevant to duties and responsibilities. Further, it can also be for other approved options such as working at another location or study.
Fringe benefits tax sideshow
Farrar's distortion (or mistake) leads him to then argue that the fringe benefits tax must apply and has to be paid by Health New Zealand. Somehow, he estimates the total additional cost to be least $23,880 (presumably per annum).
But it does not attract this tax because the entitlement is not an allowance. Perks apply to allowances, not work-related reimbursements. Much of the CME expenses are spent on consumables such as travel and accommodation. Where conferences are involved there also registration costs.
While some of these costs are close to home (Australia), our relative geographic isolation means that greater distances are required to exercise the full benefits of this necessary form of professional development and education.
The one exception where the fringe benefits tax might impact (it might instead be PAYE) is that the entitlement can be used for the personal purchase of laptops (that is, a personal capital product) for the express purpose of professional development and education. However, this requires specific employer approval and, to the extent that it happens is only a small component of the costs of the entitlement.
Farrar goes further to falsely imply that the two weeks CME itself, which is required by Health New Zealand, is also a perk.
Let me be very clear. Based on my experience in the health system, I would not want to be treated or diagnosed by a senior doctor who was not sufficiently utilising their CME leave entitlement. Patient safety has been compromised as a consequence.
Sloppy mistakes or deliberate distortion?
Finally, Farrar proceeds to make an astonishing attack on the credibility of senior doctors. He refers to something he had 'heard' (further hearsay). One employed by the health ministry had allegedly used the 'allowance' to a global conference on air pollution and health.
First, the entitlement is for Health New Zealand employed senior doctors. Second, if the person nevertheless was able to receive the same provision, it is not an allowance.
Third, a health ministry employed senior doctor able to attend this event is most likely to be a public health specialist.
If so, giving the relationship between air pollution and poor health, it would be up there among the most valuable events to attend if the health ministry were to properly perform its stewardship role for the health of New Zealand's population.
Is David Farrar's smear due to sloppy mistakes or deliberate? Readers can be the judge of that.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Otago Daily Times
a day ago
- Otago Daily Times
Public-private healthcare opportunities identified
A strategic report focused on the future of public health services in Otago Central Lakes has identified six potential opportunities for public-private collaboration. The Otago Central Lakes strategic health report was sent to Health Minister Simeon Brown in February by the steering group, which was comprised of Southland MP Joseph Mooney, Health New Zealand, the Central Otago and Queenstown Lakes District Councils, rural health providers, iwi, including kaupapa Māori health providers, Act MP Todd Stephenson and Waitaki MP Miles Anderson. Mr Mooney said the group's objective was to "expedite planning and investment in health services and infrastructure in Otago Central Lakes" — Central Otago District Mayor Tamah Alley said 70% of New Zealanders who lived two or more hours from a hospital resided in that region. The report said health service improvements were required to meet the current and future populations' needs. On a peak day, the district's combined population, which included visitors, was 168,000 — expected to nearly double by 2054, it said. "There is a reputational risk to all of Aotearoa New Zealand if adequate healthcare services are unavailable to deal with international visitor illness or injury." The report identified opportunities to increase public health services by partnering with the private sector, but Mr Anderson said the project was "not asking for public funds". The "early stage" public-private partnerships included in the report, which were "ready for collaboration", are: • The Southern Lakes Public Hospital — the location of which is to be determined — which is a proposed privately financed facility with full public hospital services and future capacity to become a regional hospital. • Lakeview Te Taumata Clinic (Queenstown), a private surgical hospital expected to open in 2027, with opportunities for maternity care and workforce development. • Integrated Care Hub (Wānaka), a planned day surgery with potential space for publicly funded after-hours services. • Wānaka Health Precinct, a private surgical hospital designed with capacity to integrate public services. • Aged-care facilities (Clyde), which are under construction, have the potential to expand into a full suite of publicly funded services for older people in Central Otago. • Securing land and investors in Central Otago for future public health infrastructure, based on the outcomes of the other projects. Additionally, the trust was exploring "innovative mobile modular units" which could be used as consultation rooms, clinics or staff accommodation and wanted to find land to host them in areas where they were needed, the report said. The $2 million funding was required to "complete the groundwork" for community consultation, clinical design and planning process, and technical assessments and detailed business cases Health New Zealand could work with — it already had $400,000 seed funding, it said. Subject to Mr Brown's support, a working group would be established to work with Health New Zealand to progress the proposed solutions — community engagement and consultation would follow.

RNZ News
2 days ago
- RNZ News
Prominent medical bodies call for release of delayed gender affirming healthcare guidelines
Te Whatu Ora was due to release the guidelines in March. Photo: RNZ / Angus Dreaver Prominent medical bodies are calling on the government to allow the release of updated gender affirming healthcare guidelines after a small section on puberty blockers caused it to be delayed. The guidelines were due to be released at the end of March but it's is now unclear when they will be. The Professional Association for Transgender Health Aotearoa, who was asked by Te Whatu Ora to update the guidelines, believes the delay is "due to unprecedented and inappropriate political interference". Te Whatu Ora says it'll publish the guidelines "once decisions are made by the government following the ministry's consultation process". Public submissions on the matter closed 20 January. But PATHA says the advice on puberty blockers in the guidelines was updated in November to reflect the Ministry of Health's new position and this was approved by Te Whatu Ora's National Clinical Governance Group. It says this advice makes up only six pages out of the total 182 pages of the document. The guidelines cover all aspects of gender-affirming care to support trans and non-binary people and their families to navigate healthcare. This includes whānau support, creating inclusive clinical environments, non-medical and non-surgical gender affirmation, speech and language therapy, fertility and sexual health, mental wellbeing, gender-affirming hormone therapy, and detransition, as well as specific guidance for Māori, Pasifika, and refugee and asylum seeker trans people, PATHA said. More than 300 medical bodies, community organisations, and individual healthcare professionals have signed an open letter calling for the government to allow Te Whatu Ora to release the guidelines. These include General Practice New Zealand (GPNZ), Royal New Zealand College of General Practitioners, The Paediatric Society of NZ, New Zealand College of Clinical Psychologists, New Zealand College of Primary Health Care Nurses, College of Child and Youth Nurses and New Zealand Nurses Organisation. PATHA president Jennifer Shields said delaying the release impacts on the ability to improve healthcare delivery and health outcomes for the transgender and non-binary population. "Less than 24 hours before the date of publication, there was an unnecessary, indefinite and unexplained delay in the publication of these clinical guidelines, we believe due to unprecedented and inappropriate political interference." In November, the government released its evidence brief on puberty blockers and a position statement which sets out its expectations for their use. It signalled its intention to consider regulating them in gender affirming care and tasked the ministry with consultation, opening up public submissions. Regulatory measures could include restricting prescribing puberty blockers in the context of gender affirming care for young people but not its use in other contexts, the ministry said. Further measures being considered by the ministry included updating clinical guidance and increasing monitoring of prescriptions. The Green Party has denounced the signalled change of approach. Medical practitioners are currently working with guidelines published in 2018. PATHA said Te Whatu Ora contacted it in 2023 to update these. "It is standard practice for guidelines to be periodically updated to ensure their content is kept up to date. PATHA submitted the updated guidelines in October 2024 and they followed the standard process for publication of a clinical guideline, and were approved by Te Whatu Ora's National Clinical Governance Group." Vice president Dr Rona Carroll said clinicians are asking for up-to-date guidance to provide appropriate and safe healthcare. "The need for this updated guidance is clear and something I hear from health professionals on a daily basis. We just want to be able to publish these guidelines so the clinicians who need them can use them." Health NZ Te Whatu Ora national clinical director primary and community care Dr Sarah Clarke said it acknowledges the guidelines currently being used are from 2018 and that the evidence base in this area continues to evolve. "In the interim, and ahead of the updated guidelines being published, our advice is that health professionals continue to provide effective care based on the best available evidence and consult and take advice from colleagues more experienced in this care when appropriate." Puberty blockers can be used as part of gender affirming care to delay the onset of puberty by suppressing oestrogen and testosterone. They are also used for precocious puberty in children, and the ministry says the same medications can be used in adults to treat endometriosis, breast and prostate cancer, and polycystic ovary syndrome. The evidence brief released in November and subsequent public consultation only looked at the use of blockers specifically as they related to gender affirming care. The ministry says overall, the evidence brief found "significant limitations in the quality of evidence for either the benefits or risks (or lack thereof) of the use of puberty blockers". Following the release of the evidence brief, the ministry directed clinicians to exercise caution in prescribing puberty blockers. At the time Shields said this was already in line with New Zealand best practice and it was reassuring to see the ministry recognise this.

RNZ News
2 days ago
- RNZ News
'HIV should not be a death sentence in Fiji' - call for testing amid outbreak
Photo: 123RF Fiji's Minister for Health & Medical Services has revealed the latest HIV numbers in the country to a development partner roundtable on the country's response. There were 490 new HIV cases from October - December last year, bringing the 2024 total to 1583. "Included in this number are 32 newborns diagnosed with HIV acquired through mother-to-child transmission," Dr Atonio Rabici Lalabalavu said. Fiji declared an outbreak of the disease in January. The Fiji Sun reported around 115 HIV-related deaths in the January-September 2024 period. Fiji's Central Division reported 1100 new cases in 2024, with 427 in the Western Division and 50 in the Northern Division. Of the newly recorded cases, less than half - 770 - have been successfully linked to care, of which 711 have been commenced on antiretroviral therapy (ART). Just over half were aged in their twenties, and 70 percent of cases were male. Dr Lalabalavu said the increase in HIV cases is also seeing an increase in tuberculosis and HIV co-infection, with 160 individuals in a year. He said the ministry strongly encourages individuals to get tested, know their status, and if it is positive, seek treatment. Atonio Lalabalavu Photo: Facebook / Ministry of Health & Medical Services And if it is negative, to maintain that negative status. "I will reiterate what I have said before to all Fijians - HIV should not be a death sentence in Fiji." In the Western Pacific, the estimated number of people living with HIV (PLHIV) reached 1.9 million in 2020, up from 1.4 million in 2010. At the time, the World Health Organisation said over the previous two decades, HIV prevalence in the Western Pacific had remained low at 0.1 percent. However, the low prevalence in the general population masked high levels of HIV infection among key populations.